Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 37 | 12.04.21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13.04.21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11.12.17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 15.08.17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 20.11.17 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15.08.17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02.02.16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 10.10.13 |
Jeff Paley
BRD | Director/Board Member | 55 | 23.02.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 3 713 | 0 | 0 | 100,00 % |
Aktie B | 1 | 172 878 093 | 172 878 093 ( 100,00 %) | 0 |
Unternehmenskontakt
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+32.91% | 698 Mrd. | |
+26.51% | 568 Mrd. | |
-4.49% | 358 Mrd. | |
+19.30% | 328 Mrd. | |
+3.57% | 283 Mrd. | |
+16.34% | 238 Mrd. | |
+6.68% | 203 Mrd. | |
-9.08% | 198 Mrd. | |
+8.69% | 165 Mrd. |